Literature DB >> 30989560

Haplotypes of CYP1B1 and CCDC57 genes in an Afro-Caribbean female population with uterine leiomyoma.

Angela T Alleyne1, Virgil S Bideau2.   

Abstract

Uterine leiomyomas (UL) are prevalent benign tumors, especially among women of African ancestry. The disease also has genetic liability and is influenced by risk factors such as hormones and obesity. This study investigates the haplotypes of the Cytochrome P450 1B1 gene (CYP1B1) related to hormones and coiled-coil domain containing 57 gene (CCDC57) related to obesity in Afro-Caribbean females. Each haplotype was constructed from unphased sequence data using PHASE v.2.1 software and Haploview v.4.2 was used for linkage disequilibrium (LD) studies. There were contrasting LD observed among the single nucleotide polymorphisms of CYP1B1 and CCDC5. Accordingly, the GTA haplotype of CYP1B1 was significantly associated with UL risk (P = 0.02) while there was no association between CCDC57 haplotypes and UL (P = 0.2) for the ATG haplotype. As such, our findings suggest that the Asp449Asp polymorphism and GTA haplotype of CYP1B1 may contribute to UL susceptibility in women of Afro-Caribbean ancestry in this population.

Entities:  

Keywords:  Estrogen; Fibroids; Haplotyping; Linkage disequilibrium; SNP

Mesh:

Substances:

Year:  2019        PMID: 30989560     DOI: 10.1007/s11033-019-04790-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  49 in total

1.  Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking.

Authors:  E Faerstein; M Szklo; N Rosenshein
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

2.  Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals.

Authors:  Dmitri V Zaykin; Peter H Westfall; S Stanley Young; Maha A Karnoub; Michael J Wagner; Margaret G Ehm
Journal:  Hum Hered       Date:  2002       Impact factor: 0.444

3.  A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids.

Authors:  Pei-Chieng Cha; Atsushi Takahashi; Naoya Hosono; Siew-Kee Low; Naoyuki Kamatani; Michiaki Kubo; Yusuke Nakamura
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

4.  Leu/Val SNP polymorphism of CYP1B1 and risk of uterine leiomyoma in a Black population.

Authors:  Virgil S Bideau; Angela T Alleyne
Journal:  Tumour Biol       Date:  2015-10-20

5.  Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas.

Authors:  M Nilbert; S Heim; N Mandahl; U M Flodérus; H Willén; F Mitelman
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

Review 6.  Uterine leiomyomata: etiology, symptomatology, and management.

Authors:  V C Buttram; R C Reiter
Journal:  Fertil Steril       Date:  1981-10       Impact factor: 7.329

7.  Association of polymorphisms and haplotypes in the cytochrome P450 1B1 gene with uterine leiomyoma: A case control study.

Authors:  Saeedeh Salimi; Maryam Khodamian; Mehrnaz Narooie-Nejad; Azam Hajizadeh; Kimia Fazeli; Lida Namazi; Minoo Yaghmaei
Journal:  Biomed Rep       Date:  2014-12-31

8.  Role of single nucleotide polymorphisms in estrogen-metabolizing enzymes and susceptibility to uterine leiomyoma in Han Chinese: a case-control study.

Authors:  Yang Shen; Qian Xu; Mulan Ren; Yunlang Cai; Jie Xu
Journal:  J Obstet Gynaecol Res       Date:  2013-12-10       Impact factor: 1.730

Review 9.  Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.

Authors:  Jennelle C Hodge; Cynthia C Morton
Journal:  Hum Mol Genet       Date:  2007-04-15       Impact factor: 6.150

10.  Evaluation of GWAS candidate susceptibility loci for uterine leiomyoma in the multi-ethnic NIEHS uterine fibroid study.

Authors:  Brahim Aissani; Kui Zhang; Howard Wiener
Journal:  Front Genet       Date:  2015-07-14       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.